Literature DB >> 16685677

Ischemic type biliary lesions in histidine-tryptophan-ketoglutarate (HTK) preserved liver grafts.

C Moench1, G Otto.   

Abstract

Ischemic type biliary lesions lead to considerable morbidity following orthotopic liver transplantation. The exact pathogenesis is unknown. One major hypothesis is that insufficient perfusion of the arterial vessels of the biliary tree, especially under perfusion with the high viscous University of Wisconsin solution, might be responsible for ischemic type biliary lesions. Due to low viscosity, HTK solution is reported to have a lower incidence of biliary complications. However, there is no data concerning ischemic type biliary lesions in HTK preserved livers. In this paper we report our results after orthotopic liver transplantation with special regard to ischemic type biliary lesions in liver grafts preserved with HTK solution. Between 09/1997 and 01/2005 300 liver transplantations were performed in our center. Thirty-two (10.7%) liver grafts were preserved with HTK solution, 268 (89.3%) were preserved with UW solution. Six and 43 grafts showed ischemic type biliary lesions after orthotopic liver transplantation in HTK- (18.8%) and UW- (16.0%) groups, respectively (p=0.696). There was no statistical significant difference between the two groups. Donor related factors, recipient age, indication for transplantation, transplantation technique, immunosuppression and ischemia time were comparable in both groups. Ischemic type biliary lesions occurred with the same frequency in HTK preserved livers compared to UW preserved organs. We suggest that low viscosity of the preservation fluid by itself does not guarantee reliable perfusion of the small arteries of a liver graft and a pressure perfusion might be beneficial even in HTK solution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685677     DOI: 10.1177/039139880602900311

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  6 in total

Review 1.  Preservation solutions used during abdominal transplantation: Current status and outcomes.

Authors:  Nicholas Latchana; Joshua R Peck; Bryan A Whitson; Mitchell L Henry; Elmahdi A Elkhammas; Sylvester M Black
Journal:  World J Transplant       Date:  2015-12-24

2.  Biliary complications following orthotopic liver transplantation: a 10-year audit.

Authors:  Nalaka Gunawansa; John L McCall; Andrew Holden; Lindsay Plank; Stephen R Munn
Journal:  HPB (Oxford)       Date:  2011-06       Impact factor: 3.647

Review 3.  Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation.

Authors:  Moustafa Mabrouk Mourad; Abdullah Algarni; Christos Liossis; Simon R Bramhall
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.

Authors:  Raffaele Cursio; Jean Gugenheim
Journal:  J Transplant       Date:  2012-02-29

5.  Comparable outcome of liver transplantation with histidine-tryptophan-ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial.

Authors:  Alexander Kaltenborn; Jill Gwiasda; Volker Amelung; Christian Krauth; Frank Lehner; Felix Braun; Jürgen Klempnauer; Benedikt Reichert; Harald Schrem
Journal:  BMC Gastroenterol       Date:  2014-09-28       Impact factor: 3.067

Review 6.  A systematic review and meta-analysis of cold in situ perfusion and preservation of the hepatic allograft: Working toward a unified approach.

Authors:  Ahmer M Hameed; Jerome M Laurence; Vincent W T Lam; Henry C Pleass; Wayne J Hawthorne
Journal:  Liver Transpl       Date:  2017-11-08       Impact factor: 5.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.